A. Gasca-Ruchti

Discipline

Psychologie (1)

Type de document

Co-auteur

R.A. Stahel

J. Spicer

R. Shah

S. Rusakiewicz

B. Ruepp

A. Roy

H. Roschitzki-Voser

A. Pope

S. Popat

V. Polydoropoulou

S Peters

O'Brien, M.

E. Nadal

R. López Castro

I. Letovanec

W.D. Janthur

D. Gilligan

O. Gautschi

R. García Campelo

P. Fisher

U. Dafni

A. Curioni-Fontecedro

Source

Serveur académique Lausannois (1)

Mot-clé

sécurité (1) oncologie (1) danger (1) point (1) procès (1) taux (1) survie (1) Treatment (1) Chemotherapy (1) Inhibitors (1) Observations (1) Observations (1) Ci (Chinese poetry) (1) Trials (1) Survival (1) Prognosis (1) Poor (1) Performance (1) Patients (1) Oncology (1) Months (1) Mesothelioma (1) Inhibition (1) Confidence (1) Chemotherapy (1) Cell death (1) Vinorelbine (1) September (1) February (1) Relapse (1)

Documents écrit par A. Gasca-Ruchti (1) | parle de A. Gasca-Ruchti (0)

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.

S. Popat et al.